Immunosuppressive Agents: all 5,940 studies that test it
Page 46 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric JunctionCompletedNCT01042782Phase 1
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back PainCompletedNCT01040195Phase 3
- TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple MyelomaCompletedNCT01039025Phase 2
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy AdultsCompletedNCT01038167Phase 1
- Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant RecipientsStatus unknownNCT01034345Phase 2
- Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic PatientsWithdrawnNCT01033500Not applicable
- Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)CompletedNCT01033305Phase 2
- Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)Status unknownNCT01031030Phase 3
- Etanercept for the Treatment of Chronic UrticariaWithdrawnNCT01030120Phase 2/3
- Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With EndometriosisTerminatedNCT01028781Phase 1
- Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection EpisodesCompletedNCT01028443Phase 4
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal TransplantationCompletedNCT01028092Phase 3
- A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years OldCompletedNCT01026116Phase 3
- Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic CarcinomaActive, not recruitingNCT01025089Phase 2
- Optimizing Cimzia in Crohn's PatientsStatus unknownNCT01024647Phase 4
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk LeukemiaCompletedNCT01020539Phase 1
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesCompletedNCT01019876Phase 2/3
- Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01019174Phase 1/2
- A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation PatientsCompletedNCT01018914Phase 4
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic ArthritisCompletedNCT01015547Phase 3
- Rapamycin and Regulatory T Cells in Kidney TransplantationCompletedNCT01014234Phase 2
- Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver TransplantationCompletedNCT01011205Phase 3
- SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01010581Phase 2
- Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's LymphomaStatus unknownNCT01009970Phase 2
- Everolimus on CKD Progression in ADPKD PatientsTerminatedNCT01009957Phase 2/3
- Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow EmigrantsWithdrawnNCT01009879Phase 4
- Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver CancerTerminatedNCT01009801Phase 1/2
- Efficacy and Safety of Belimumab in Primary Sjögren's SyndromeCompletedNCT01008982Phase 2
- Autologous Transplantation for Chronic Myelogenous LeukemiaCompletedNCT01003054Phase 2
- Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host DiseaseWithdrawnNCT01001780Phase 2
- Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisCompletedNCT01000441Phase 4
- Low Dose Cyclophosphamide Treats Genital WartsCompletedNCT00999986Phase 3
- Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant RecipientsStatus unknownNCT00999258Phase 4
- Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00994968Phase 2
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
- Trial of Cyclosporine for Myocardial Protection During Open Heart SurgeryTerminatedNCT00990795Phase 1
- GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy SubjectsCompletedNCT00989703Phase 1
- Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-LymphomaStatus unknownNCT00989352Phase 2
- Pharmacological Postconditioning During the Aortic Valvular SurgeryCompletedNCT00987207Phase 3
- Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant PatientsStatus unknownNCT00987103Phase 1
- A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid TumorsTerminatedNCT00985374Phase 1
- Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)CompletedNCT00981708Phase 1/2
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Everolimus as First-Line Therapy in Treating Patients With Prostate CancerCompletedNCT00976755Phase 2
- Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune StudyCompletedNCT00976300Phase 2
- Bayesian Dose Adjustment of Immunosuppressants After Lung TransplantationTerminatedNCT00975663Phase 4
- Study of RAD001 in Advanced Cholangiocarcinoma: RADiCholStatus unknownNCT00973713Phase 2
- Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaCompletedNCT00971763Phase 2
- Pharmacokinetics of Everolimus in Subjects With Hepatic InsufficiencyCompletedNCT00968591Phase 1
- Everolimus Dose Finding Study for Stage IV or Recurrent Cervical CancerWithdrawnNCT00967928Phase 1
- Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic TreatmentsCompletedNCT00967538Phase 4
- Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus TherapyStatus unknownNCT00966836Phase 3
- Pilot Study of Etanercept (Enbrel) in Children With Fanconi AnemiaCompletedNCT00965666Early Phase 1
- A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT00965653Phase 1
- Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3
- Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCompletedNCT00962507Phase 1
- RMPT for Relapsed/Refractory Multiple MyelomaCompletedNCT00961467Phase 2
- Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseStatus unknownNCT00959231Phase 2
- Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell LymphomaStatus unknownNCT00958854Phase 2
- Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT00957320Phase 1
- Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisStatus unknownNCT00956059Not applicable
- A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer SubjectsCompletedNCT00955773Phase 1
- Methotrexate in Metastatic Colorectal Cancer With MSH2 DeficiencyTerminatedNCT00952016Phase 2
- Enhancement of Functional Recovery After Peripheral Nerve Injury With TacrolimusWithdrawnNCT00950391Phase 1/2
- Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyCompletedNCT00949949Phase 1
- Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell TransplantationCompletedNCT00948727Phase 2
- Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus MesalazineCompletedNCT00946946Phase 3
- To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00946686Phase 1
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
- Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
- High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple SclerosisWithdrawnNCT00939549Phase 2
- T-cell Based Immunotherapy for of MelanomaCompletedNCT00937625Phase 1/2
- RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerCompletedNCT00935961Phase 1
- Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal TransplantationCompletedNCT00935298Phase 4
- A Study of High-Risk Oral Cavity CancerTerminatedNCT00934739Phase 2/3
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell TransplantationStatus unknownNCT00934557Phase 3
- Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple MyelomaCompletedNCT00934154Phase 3
- Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial CarcinomaTerminatedNCT00933374Phase 2
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedNCT00933231Phase 3
- Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's DiseaseStatus unknownNCT00931957Not applicable
- Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast CancerStatus unknownNCT00930475Phase 1/2
- Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung TransplantationTerminatedNCT00930241Phase 3
- Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney TransplantTerminatedNCT00928811Phase 2/3
- Topical Rapamycin for FibrofolliculomasCompletedNCT00928798Phase 3
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedNCT00927966Phase 1
- Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)Status unknownNCT00927797Phase 2
- Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
- Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate CancerWithdrawnNCT00922129Phase 2/3
- Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular CarcinomaStatus unknownNCT00921531Phase 3
- A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis PatientsWithdrawnNCT00920608Phase 1
- Ciclosporin in the Management of New Type 1 Reactions in LeprosyCompletedNCT00919815Phase 2/3
- Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum LeprosumCompletedNCT00919776Phase 2
- Ciclosporin in the Management of New Erythema Nodosum LeprosumCompletedNCT00919542Phase 2
- Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in LeprosyCompletedNCT00919451Phase 2
- Efficacy Study of Methotrexate to Treat Sarcoid-associated UveitisTerminatedNCT00918554Phase 4
- Pilot Study of Unrelated Cord Blood TransplantationTerminatedNCT00916045Phase 2